Search all trials

Find therapies in clinical trials near you – page 2

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Factor VIII deficiency

Recruiting

Registered drugNo placebo

Study on the Use of Simoctocog Alfa for Women and Girls with Hemophilia A Undergoing Surgery

Registered drugNo placebo

Finland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Simoctocog Alfa

Contact Research Centre

Factor VIII deficiency+1

Not yet recruiting

Registered drugNo placebo

Study on Joint Health in Hemophilia A and B Patients Using Efmoroctocog Alfa or Eftrenonacog Alfa

Registered drugNo placebo

Bulgaria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Efmoroctocog Alfa

Contact Research Centre

Factor VIII deficiency+1

Not recruiting

InvestigationalNo placebo

A study looking at the safety of switching from emicizumab to denecimig in adults and adolescents with haemophilia A with or without inhibitors

InvestigationalNo placebo

Austria

Participants:0–17 years · 18–64 years · 65+ years

Contact Research Centre

Factor VIII deficiency

Not recruiting

Registered drugNo placebo

Study on Long-Term Effects of Efanesoctocog Alfa in Preventing Joint Bleeds in Patients with Hemophilia A

Registered drugNo placebo

Croatia

Participants:0–17 years · 18–64 years · 65+ years
Substances:Efanesoctocog Alfa

Contact Research Centre

Factor VIII deficiency

Not recruiting

Registered drugNo placebo

Study on Emicizumab for Patients with Mild or Moderate Hemophilia A Without FVIII Inhibitors

Registered drugNo placebo

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Emicizumab

Contact Research Centre

Factor VIII deficiency

Not recruiting

Registered drugNo placebo

Study on Synovial Hypertrophy in Patients with Hemophilia A Using Efanesoctocog Alfa Prophylaxis

Registered drugNo placebo

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Efanesoctocog Alfa

Contact Research Centre

Factor VIII deficiency+1

Not recruiting

InvestigationalNo placebo

Study on How Concizumab Works for Patients with Hemophilia A or B Without Inhibitors

InvestigationalNo placebo

Denmark

Participants:0–17 years · 18–64 years · 65+ years
Substances:Concizumab

Contact Research Centre

Factor VIII deficiency

Not recruiting

Registered drugNo placebo

Safety Study of Damoctocog Alfa Pegol for Children Aged 7 to 11 with Severe Hemophilia A

Registered drugNo placebo

Italy

Participants:0–17 years
Substances:Damoctocog Alfa Pegol

Contact Research Centre

Factor VIII deficiency

Not recruiting

InvestigationalNo placebo

Study on the Safety and Effectiveness of Giroctocogene Fitelparvovec for Adult Men with Moderate to Severe Hemophilia A

InvestigationalNo placebo

France

Participants:18–64 years
Substances:Giroctocogene Fitelparvovec

Contact Research Centre

Factor VIII deficiency

Not recruiting

Registered drugNo placebo

Long-Term Safety Study of Valoctocogene Roxaparvovec for Patients with Severe Hemophilia A

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Valoctocogene Roxaparvovec

Contact Research Centre

Factor VIII deficiency

Not recruiting

InvestigationalNo placebo

Study on the Safety and Effects of BAY 2599023 (Peboctocogene Camaparvovec) for Adults with Severe Hemophilia A

InvestigationalNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Peboctocogene Camaparvovec

Contact Research Centre

Factor VIII deficiency

Not recruiting

InvestigationalNo placebo

Study on Physical Activity and Joint Health in Patients Aged 12 and Older with Severe Hemophilia A Treated with Efanesoctocog Alfa for 24 Months

InvestigationalNo placebo

Austria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Efanesoctocog Alfa

Contact Research Centre

Find therapies in clinical trials near you – page 2

25 trials match your criteria

Factor VIII deficiency

Study on the Use of Simoctocog Alfa for Women and Girls with Hemophilia A Undergoing Surgery

Factor VIII deficiency+1

Study on Joint Health in Hemophilia A and B Patients Using Efmoroctocog Alfa or Eftrenonacog Alfa

Factor VIII deficiency+1

A study looking at the safety of switching from emicizumab to denecimig in adults and adolescents with haemophilia A with or without inhibitors

Factor VIII deficiency

Study on Long-Term Effects of Efanesoctocog Alfa in Preventing Joint Bleeds in Patients with Hemophilia A

Factor VIII deficiency

Study on Emicizumab for Patients with Mild or Moderate Hemophilia A Without FVIII Inhibitors

Factor VIII deficiency

Study on Synovial Hypertrophy in Patients with Hemophilia A Using Efanesoctocog Alfa Prophylaxis

Factor VIII deficiency+1

Study on How Concizumab Works for Patients with Hemophilia A or B Without Inhibitors

Factor VIII deficiency

Safety Study of Damoctocog Alfa Pegol for Children Aged 7 to 11 with Severe Hemophilia A

Factor VIII deficiency

Study on the Safety and Effectiveness of Giroctocogene Fitelparvovec for Adult Men with Moderate to Severe Hemophilia A

Factor VIII deficiency

Long-Term Safety Study of Valoctocogene Roxaparvovec for Patients with Severe Hemophilia A

Factor VIII deficiency

Study on the Safety and Effects of BAY 2599023 (Peboctocogene Camaparvovec) for Adults with Severe Hemophilia A

Factor VIII deficiency

Study on Physical Activity and Joint Health in Patients Aged 12 and Older with Severe Hemophilia A Treated with Efanesoctocog Alfa for 24 Months

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.